David N. Gill - Jul 15, 2022 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role: Director
Signature: /s/ Sune Reinholth Nyland, Attorney-in-Fact for David N. Gill
Stock symbol: YMAB
Transactions as of: Jul 15, 2022
Transactions value $: $0
Form type: 4
Date filed: 7/19/2022, 01:20 PM
Previous filing: May 17, 2022
Next filing: Jan 31, 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	YMAB	Non-Employee Stock Option (right to buy)	Award	$0	+16K		$0.00	16K	Jul 15, 2022	Common Stock	16K	$16.64	Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Stock options granted to the Reporting Person as a non-employee director pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
F2	The stock options vest in equal monthly installments during the first year following the date of grant, subject to the Reporting Person's continued service to Y-mAbs Therapeutics, Inc., and are exercisable immediately upon vesting.

Remarks:

Exhibit Index: Exhibit 24 - Power of Attorney for David N. Gill dated July 15, 2022